The impact of sodium-glucose co-transporter-2 inhibitors on dementia and cardiovascular events in diabetic patients with atrial fibrillation.

Yun-Yu ChenHao-Chih ChangYenn-Jiang LinKuo-Liong ChienYu Cheng HsiehFa-Po ChungChing-Heng LinGregory Y H LipShih-Ann Chen

Published in: Diabetes/metabolism research and reviews (2024)

In diabetic patients with AF, SGLT2i was associated with reduced risks of incident dementia, AF-related hospitalisation, stroke, and all-cause death. The protective effects were independent of either concurrent use of NOACs or DPP4i.

Keyphrases

cardiovascular events
atrial fibrillation
mild cognitive impairment
cardiovascular disease
coronary artery disease
type diabetes
cognitive impairment
oral anticoagulants
wound healing
human health
locally advanced
squamous cell carcinoma
cerebral ischemia
climate change
blood brain barrier